TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo

TURK İLAÇ VE SERUM SANAYİ A.Ş.

TRILC | IS

Overview

Corporate Details

ISIN(s):
TRETRLC00014 (+1 more)
LEI:
78900003BNEUMO8X3Y93
Country:
Türkiye
Address:
BÜĞDÜZ MAH. ENVER PAŞA CAD. NO: 8 AKYURT / ANKARA, 06750 ANKARA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Turk İlaç ve Serum Sanayi A.Ş. is a pharmaceutical company focused on the production of human medicines and vaccines. The company operates Turkey's highest-capacity manufacturing facility for IV Parenteral Solutions (serum) and also produces a range of products in ampoule and vial forms. A key milestone for the company was the establishment of the country's first private vaccine production facility. Operating in accordance with Good Manufacturing Practice (GMP) standards, Turk İlaç is a major domestic supplier, emphasizing national production capabilities.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for TURK İLAÇ VE SERUM SANAYİ A.Ş.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-03 17:47
Regulatory News Service
Borçlanma Aracı İhracına İlişkin Yönetim Kurulu Kararı Alınması
Turkish 4.9 KB
2025-08-20 08:58
Regulatory News Service
Türkmenİstan Sağlık ve İlaç Bakanlığı ile imzalanan Sözleşmenin Sevkiyatlarının…
Turkish 17.8 KB
2025-08-18 20:29
Regulatory News Service
Participation Finance Principles Information Form
Turkish 52.6 KB
2025-08-13 09:08
Regulatory News Service
DMO İhale Sonucu Hakkında
Turkish 42.1 KB
2025-08-11 18:29
Regulatory News Service
Sorumluluk Beyanı
Turkish 20.4 KB
2025-08-11 18:29
Regulatory News Service
Financial Report
Turkish 2.0 MB
2025-08-11 18:29
Regulatory News Service
Financial Report
Turkish 2.5 MB
2025-08-11 18:29
Regulatory News Service
Faaliyet Raporu
Turkish 2.5 MB
2025-08-11 18:29
Regulatory News Service
Faaliyet Raporu
Turkish 11.0 KB
2025-08-04 14:36
Regulatory News Service
Finansman Bonosu İtfası Hakkında
Turkish 18.0 KB
2025-08-04 08:24
Regulatory News Service
Satışın Tamamlanması Hakkında
Turkish 18.2 KB
2025-07-30 14:01
Regulatory News Service
Borçlanma Aracı İhracı Hk.
Turkish 17.9 KB
2025-07-30 07:57
Regulatory News Service
Bağımsız Denetim Firması Hakkında
Turkish 29.1 KB
2025-07-30 07:51
Regulatory News Service
Kayıtlı Sermaye Tavanı ve Süre Uzatımı Tescili Hakkında.
Turkish 1.6 MB
2025-07-30 07:51
Regulatory News Service
Kayıtlı Sermaye Tavanı ve Süre Uzatımı Tescili Hakkında.
Turkish 7.1 KB

Automate Your Workflow. Get a real-time feed of all TURK İLAÇ VE SERUM SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for TURK İLAÇ VE SERUM SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK